All Stories

  1. Oro-facial mucocutaneous manifestations of Coronavirus Disease-2019 (COVID-19): A systematic review
  2. Orofacial Mycoses in Coronavirus Disease-2019 (COVID-19): A Systematic Review
  3. Diversity of site-specific microbes of occlusal and proximal lesions in severe- early childhood caries (S-ECC)
  4. Emerging and future strategies in the management of recalcitrant Candida auris
  5. Morphotypes of the apical constriction of maxillary molars: a micro-computed tomographic evaluation
  6. Tea extracts inhibit the attachment of streptococci to oral/dental substrata by reducing hydrogen bonding energies
  7. Current COVID-19 vaccine epidemiology and dentistry
  8. Oral pemphigus after COVID‐19 vaccination
  9. The effect of the combined use of silver diamine fluoride and potassium iodide in disrupting the plaque biofilm microbiome and alleviating tooth discoloration: A systematic review
  10. Coronavirus disease 2019 (COVID‐19) vaccines: A concise review
  11. A curcumin-sophorolipid nanocomplex inhibits Candida albicans filamentation and biofilm development
  12. Teeth with Apical Periodontitis Obturated in the Presence or Absence of Cultivable Micro-Organisms: A Two-Year Prospective Study of Treatment Outcomes
  13. Tea extracts modulate oral biofilm development by altering bacterial hydrophobicity and aggregation
  14. Antibiotic prescribing practices of dentists for endodontic infections; a cross-sectional study
  15. Attributes of dysgeusia and anosmia of coronavirus disease 2019 (COVID‐19) in hospitalized patients
  16. The antibacterial efficacy of silver diamine fluoride (SDF) is not modulated by potassium iodide (KI) supplements: A study on in-situ plaque biofilms using viability real-time PCR with propidium monoazide
  17. The Proteome of Community Living Candida albicans Is Differentially Modulated by the Morphologic and Structural Features of the Bacterial Cohabitants
  18. Concerns and fears of Indian dentists on professional practice during the coronavirus disease 2019 (COVID‐19) pandemic
  19. Facial protection in the era of COVID‐19: A narrative review
  20. <strong>Sudden Onset, Acute Loss of Taste and Smell in Coronavirus Disease 2019 (COVID-19): A Systematic Review</strong>
  21. Clinical efficacy and the antimicrobial potential of silver formulations in arresting dental caries: a systematic review
  22. Facial Protection in the Era of COVID-19: A Narrative Review
  23. Knowledge, Awareness and Perceptions of Coronavirus Disease 2019 (COVID-19) in a Cohort of Indian Dental Professionals: A Questionnaire-Based Study
  24. Silver diamine fluoride (SDF) used in childhood caries management has potent antifungal activity against oral Candida species
  25. Biodiversity of the human oral mycobiome in health and disease
  26. Effect of culture media and nutrients on biofilm growth kinetics of laboratory and clinical strains of Enterococcus faecalis
  27. Effect of oral hygiene interventions on opportunistic pathogens in patients after stroke
  28. Fluconazole resistance in Candida glabrata is associated with increased bud formation and metallothionein production
  29. Antibacterial effects of silver diamine fluoride on multi-species cariogenic biofilm on caries
  30. Preventing root caries development under oral biofilm challenge in an artificial mouth
  31. The effects of natural compounds-containing mouthrinses on patients with fixed orthodontic appliance treatment: clinical and microbiological outcomes
  32. Pseudomonas aeruginosalipopolysaccharide inhibits Candida albicanshyphae formation and alters gene expression during biofilm development
  33. Fluoride and silver concentrations of silver diammine fluoride solutions for dental use
  34. Biocide resistance of Candida and Escherichia coli biofilms is associated with higher antioxidative capacities
  35. Prevalence of oral mucosal lesions in adults undergoing highly active antiretroviral therapy in Hong Kong
  36. Effectiveness of oral hygiene interventions against oral and oropharyngeal reservoirs of aerobic and facultatively anaerobic gram-negative bacilli
  37. Microbial chemical signaling: a current perspective
  38. Low virulent oral Candida albicans strains isolated from smokers
  39. Unraveling the resistance of microbial biofilms: Has proteomics been helpful?
  40. Potent Antifungal Activity of Pure Compounds from Traditional Chinese Medicine Extracts against Six OralCandidaSpecies and the Synergy with Fluconazole against Azole-ResistantCandida albicans
  41. Sterilization and Disinfection
  42. Novel and conventional assays in determining abundance of Streptococcus mutans in saliva
  43. Oral health promotion interventions on oral reservoirs of staphylococcus aureus: a systematic review
  44. Comparison of the antimicrobial activity of Listerine and Corsodyl on orthodontic brackets in vitro
  45. A systematic review of the effectiveness of oral health promotion activities among patients with cardiovascular disease
  46. Transcriptional regulation of drug-resistance genes in Candida albicans biofilms in response to antifungals
  47. Antifungal Susceptibility and Virulence Attributes of Bloodstream Isolates of Candida from Hong Kong and Finland
  48. Oral health promotion interventions on oral yeast in hospitalised and medically compromised patients: a systematic review
  49. Enhancement of Secretory Aspartyl Protease production in biofilms of Candida albicans exposed to sub-inhibitory concentrations of fluconazole
  50. Prunus mume extract exhibits antimicrobial activity against pathogenic oral bacteria
  51. Genotypic, phenotypic, and proteomic characterization of Candida glabrata during sequential fluconazole exposure
  52. Antimicrobial Activity of Traditional Chinese Medicines on Common Oral Bacteria
  53. The antimicrobial efficacy of Fructus mume extract on orthodontic bracket: A monospecies-biofilm model study in vitro
  54. Ultrastructure and morphology of biofilms on thermoplastic orthodontic appliances in 'fast' and 'slow' plaque formers
  55. Non-steroidal anti-inflammatory drugs may modulate the protease activity of Candida albicans
  56. Time-related Increase of Staphylococci, Enterobacteriaceae and Yeasts in the Oral Cavities of Comatose Patients
  57. Bacterial lipopolysaccharides variably modulate in vitro biofilm formation of Candida species
  58. Shedding dynamics of Epstein-Barr virus: A type 1 carcinogen
  59. The post-antifungal effect (PAFE) of amphotericin B, nystatin, ketoconazole and 5-fluorocytosine and its impact on the colonization traits ofCandida glabrata
  60. Prevalence and antifungal drug sensitivity of non-albicans Candida in oral rinse samples of self-caring elderly
  61. Antimicrobial activity of Chinese medicine herbs against common bacteria in oral biofilm. A pilot study
  62. Photodynamic inactivation ofCandida albicansby BAM-SiPc
  63. Pseudomonas aeruginosa inhibits in-vitro Candida biofilm development
  64. Immune reconstitution inflammatory syndrome after highly active antiretroviral therapy: a review
  65. Experimental superficial candidiasis on tissue models
  66. Exploring the oral bacterial flora: current status and future directions
  67. Human oral keratinocyte E-cadherin degradation byCandida albicansandCandida glabrata
  68. Proteomics of drug resistance inCandida glabratabiofilms
  69. Susceptibility of Candida albicans filamentation-defective mutants to clinical biocides
  70. Expression and localization of cystic fibrosis transmembrane conductance regulator in human gingiva
  71. Bioactivity and architecture ofCandida albicansbiofilms developed on poly(methyl methacrylate) resin surface
  72. Escherichia coli and its lipopolysaccharide modulate in vitro Candida biofilm formation
  73. Community lifestyle ofCandidain mixed biofilms: a mini review
  74. Architectural analysis, viability assessment and growth kinetics of Candida albicans and Candida glabrata biofilms
  75. Effect of filamentation and mode of growth on antifungal susceptibility of Candida albicans
  76. Effect of amine fluoride-stannous fluoride preparations on oral yeasts in the elderly: a randomised placebo-controlled trial
  77. The effects of orthodontic appliances onCandidain the human mouth
  78. Differential modulation of human β-defensins expression in human gingival epithelia by Porphyromonas gingivalis lipopolysaccharide with tetra- and penta-acylated lipid A structures
  79. Proposal of a low-cost protocol for colorimetric semi-quantification of secretory phospholipase by Candida albicans grown in planktonic and biofilm phases
  80. The role of salivary factors in persistent oral carriage of Candida in humans
  81. Enhancement of Candida albicans Virulence After Exposition to Cigarette Mainstream Smoke
  82. In vitro synergistic effects of metergoline and antifungal agents against Candida krusei
  83. Cell surface hydrophobicity ofCandida albicansisolated from elder patients undergoing denture-related candidosis
  84. Microbiology of Odontogenic Bacteremia: beyond Endocarditis
  85. Commensal Oral Candida in Asian Cohorts
  86. Distribution Coefficients of Dietary Sugars in Artificial Candida Biofilms
  87. Oral mucosal fungal infections
  88. Synergistic activity of lysozyme and antifungal agents against Candida albicans biofilms on denture acrylic surfaces
  89. Microbiology of Odontogenic Bacteremia: beyond Endocarditis
  90. Candidacidal activity of black tea polyphenols
  91. The role of candidal histolytic enzymes on denture-induced stomatitis in patients living in retirement homes
  92. Oral Candidosis in HIV-Infected Patients
  93. Phenotypic evaluation of the effect of anaerobiosis on some virulence attributes of Candida albicans
  94. Biofilm lifestyle of Candida: a mini review
  95. Cell Density and Cell Aging as Factors Modulating Antifungal Resistance of Candida albicans Biofilms
  96. Candida albicans biofilm formation is associated with increased anti-oxidative capacities
  97. A Comparative Study of Candidal Invasion in Rabbit Tongue Mucosal Explants and Reconstituted Human Oral Epithelium
  98. Green antibiotics
  99. Antimicrobials as a contributory factor in oral candidosis – a brief overview
  100. Genotypic variation of Candida albicans during orthodontic therapy
  101. Characteristics of dual species Candida biofilms on denture acrylic surfaces
  102. Dietary sugars, serum and the biocide chlorhexidine digluconate modify the population and structural dynamics of mixedCandida albicansandEscherichia colibiofilms
  103. Phospholipase, proteinase and haemolytic activities of Candida albicans isolated from oral cavities of patients with type 2 diabetes mellitus
  104. In vitro biofilm formation of Candida albicans and non-albicans Candida species under dynamic and anaerobic conditions
  105. Potent anti-microbial activity of traditional Chinese medicine herbs against Candida species
  106. IL-1?, IL-1ra and IL-8 are differentially induced by Candida in experimental oral candidiasis
  107. Prevalence of oral Candida species in leprosy patients from Cambodia and Thailand
  108. Oral carriage of yeasts and coliforms in stroke sufferers: a prospective longitudinal study
  109. Oral submucous fibrosis and oral yeast carriage ? a case control study in Sri Lankan patients
  110. Candida albicans Biofilms Produce More Secreted Aspartyl Protease than the Planktonic Cells
  111. Differential phospholipase gene expression byCandida albicansin artificial media and cultured human oral epithelium
  112. Hyphal Invasion of Candida albicans Inhibits the Expression of Human β-Defensins in Experimental Oral Candidiasis
  113. Quantitative evaluation of tissue invasion by wild type, hyphal and SAP mutants of Candida albicans, and non-albicans Candida species in reconstituted human oral epithelium
  114. Effect of oral bacteria on growth and survival of Candida albicans biofilms
  115. Diabetes mellitus as a contributory factor in oral candidosis
  116. (B1) Candida and Mycotic Infections
  117. Interspecies variation in Candida biofilm formation studied using the Calgary biofilm device
  118. In vitro adhesion of Candida species to denture base materials
  119. Identification of Cultivable Microorganisms from Root Canals with Apical Periodontitis Following Two-Visit Endodontic Treatment with Antibiotics/Steroid or Calcium Hydroxide Dressings
  120. In vitro antifungal effect of amine fluoride-stannous fluoride combination on oral Candida species
  121. Expression of human β-defensin-3 in gingival epithelia
  122. Clindamycin in dentistry: More than just effective prophylaxis for endocarditis?
  123. Characterization of Switch Phenotypes in Candida albicans Biofilms
  124. Identification of Cultivable Microorganisms from Primary Endodontic Infections with Exposed and Unexposed Pulp Space
  125. Phospholipase B enzyme expression is not associated with other virulence attributes in Candida albicans isolates from patients with human immunodeficiency virus infection
  126. Frequent allelic loss of 21q11.1∼q21.1 region in advanced stage oral squamous cell carcinoma
  127. An ultrastructural and a cytochemical study of candidal invasion of reconstituted human oral epithelium
  128. The use of new probes and stains for improved assessment of cell viability and extracellular polymeric substances in Candida albicans biofilms
  129. Oral Candida species and betel quid-associated oral lesions in Padaung women of Northern Thailand
  130. In Vitro Method To Study Antifungal Perfusion in Candida Biofilms
  131. Coaggregation profiles of the microflora from root surface caries lesions
  132. Genotypic diversity of oralActinomyces naeslundiigenospecies 1 and 2 in caries-active preschool children
  133. The effect of fixed orthodontic appliances on the oral carriage of Candida species and Enterobacteriaceae
  134. Cytotoxic drugs, radiotherapy and oral candidiasis
  135. In vitro growth, acidogenicity and cariogenicity of predominant human root caries flora
  136. Molecular evaluation of residual endodontic microorganisms after instrumentation, irrigation and medication with either calcium hydroxide or Septomixine
  137. Biofilm formation of Candida albicans is variably affected by saliva and dietary sugars
  138. Oral candidosis and associated Candida species in HIV-infected Cambodians exposed to antimycotics. Orale Candidose und Candida-Spezies bei HIV-seropositiven Kambodschanern unter Antimykotika-Therapie
  139. Direct detection of cell surface interactive forces of sessile, fimbriated and non-fimbriated Actinomyces spp. using atomic force microscopy
  140. Expression of human beta-defensins-1 and -2 peptides in unresolved chronic periodontitis
  141. Severe Acute Respiratory Syndrome (SARS) and the GDP. Part II: Implications for GDPs
  142. Fungicidal effect of three new synthetic cationic peptides against Candida albicans
  143. Severe Acute Respiratory Syndrome (SARS) and the GDP. Part I: Epidemiology, virology, pathology and general health issues
  144. Reverse transcriptase polymerase chain reaction (RT-PCR) detection of HLP gene expression in Candida glabrata and its possible role in in vitro haemolysin production
  145. The effect of antiretroviral therapy on the prevalence of HIV-associated oral candidiasis in a Spanish cohort
  146. Glass fibre-reinforced composite laced with chlorhexidine digluconate and yeast adhesion
  147. Direct detection of Actinomyces spp. from infected root canals in a Chinese population: a study using PCR-based, oligonucleotide-DNA hybridization technique
  148. Adhesion and cell-surface-hydrophobicity of sequentially isolated genetic isotypes of Candida albicans in an HIV-infected Southern Chinese cohort. Adharenz und Zelloberflachen-Hydrophobizitat von sequentiell isolierten genetischen Isotypen von Candida ...
  149. Biofilm-Forming Ability of Candida albicans Is Unlikely To Contribute to High Levels of Oral Yeast Carriage in Cases of Human Immunodeficiency Virus Infection
  150. Chronic Hyperplastic Candidosis/Candidiasis (Candidal Leukoplakia)
  151. Development of novel oligonucleotide probes for seven Actinomyces species and their utility in supragingival plaque analysis
  152. `Genotypic shuffling’ of sequential clones of Candida albicans in HIV-infected individuals with and without symptomatic oral candidiasis
  153. Artificial mouth model systems and their contribution to caries research: a review
  154. Phenotypic diversity of oral C. albicans isolated on single and sequential visits in an HIV-infected Chinese cohort
  155. Oral colonisation by aerobic and facultatively anaerobic Gram-negative rods and yeast in Tibetans living in Lhasa
  156. Brief Exposure to Antimycotics Reduces the Extracellular Phospholipase Activity of Candida albicans and Candida tropicalis
  157. <i>Actinomyces</i> spp. in Supragingival Plaque of Ethnic Chinese Preschool Children with and without Active Dental Caries
  158. High Oral Prevalence of Candida krusei in Leprosy Patients in Northern Thailand
  159. Case Report. Oro-facial manifestations ofPenicillium marneffeiinfection in a Thai patient with AIDS
  160. Betel quid-associated oral lesions and oral Candida species in a female Cambodian cohort
  161. Candida glabrata, an emerging fungal pathogen, exhibits superior relative cell surface hydrophobicity and adhesion to denture acrylic surfaces compared with Candida albicans
  162. Candidiasis and other fungal diseases of the mouth
  163. Susceptibility of Candida albicans isolates from the oral cavities of HIV-positive patients to histatin-5
  164. Fungal infections associated with HIV infection
  165. Impact of lysozyme and lactoferrin on oral Candida isolates exposed to polyene antimycotics and fluconazole
  166. Bacterial and yeast flora of root surface caries in elderly, ethnic Chinese
  167. Characterization, heterologous expression and functional analysis of mevalonate diphosphate decarboxylase gene (MVD) of Candida albicans
  168. Molecular heterogeneity of fluconazole-resistant and -susceptible oral Candida albicans isolates within a single geographic locale
  169. Cariogenic traits in xylitol-resistant and xylitol-sensitive mutans streptococci
  170. Impact of Brief, Sequential Exposure to Fluconazole and Amphotericin B on the Cell Surface Hydrophobicity of oral Candida albicans Isolates Obtained from HIV Infected Patients
  171. Antifungal Effects of Lysozyme and Lactoferrin against Genetically Similar, Sequential Candida albicans Isolates from a Human Immunodeficiency Virus-Infected Southern Chinese Cohort
  172. Candida Species Exhibit Differential In Vitro Hemolytic Activities
  173. Effects of Two Different Growth Media on the Postantifungal Effect Induced by Polyenes on Candida Species
  174. Heterogeneity in antifungal susceptibility of clones of Candida albicans isolated on single and sequential visits from a HIV-infected southern Chinese cohort
  175. Experimental Oral Candidiasis in Animal Models
  176. Phenotypes and randomly amplified polymorphic DNA profiles of Candida albicans isolates from root canal infections in a Finnish population
  177. The impact of chlorhexidine gluconate on the relative cell surface hydrophobicity of oral Candida albicans
  178. Adhesion of Candida parapsilosis to epithelial and acrylic surfaces correlates with cell surface hydrophobicity
  179. Oral colonization of aerobic and facultatively anaerobic gram-negative rods and cocci in irradiated, dentate, xerostomic individuals
  180. Evaluation of Polyene-Azole Antagonism in Liquid Cultures of Candida albicans Using an Automated Turbidometric Method
  181. Investigative Methods for Studying the Adhesion and Cell Surface Hydrophobicity ofCandidaSpecies: An Overview
  182. Oral yeasts and coliforms in HIV-infected individuals in Hong Kong
  183. Effect of serum concentration on Candida biofilm formation on acrylic surfaces
  184. Sub-therapeutic exposure to polyene antimycotics elicits a post-antifungal effect (PAFE) and depresses the cell surface hydrophobicity of oral Candida albicans isolates
  185. Homozygous deletion of the PTEN tumor-suppressor gene is not a feature in oral squamous cell carcinoma
  186. Adhesion of oral Candida species to human buccal epithelial cells following brief exposure to nystatin
  187. Factors affecting the adherence of Candida albicans to human buccal epithelial cells in human immunodeficiency virus infection
  188. Up-regulation of Fas ligand and down-regulation of Fas expression in oral carcinogenesis
  189. <tocheading>Original Articles</tocheading>
  190. Inhibition of Growth and Secreted Aspartyl Proteinase Production in Candida Albicans by Lysozyme
  191. In vitro susceptibility of Candida species to lactoferrin
  192. Effects of modified pellicles onCandidabiofilm formation on acrylic surfaces
  193. Adhesion of oral Candida albicans isolates to denture acrylic following limited exposure to antifungal agents
  194. Caries removal techniques and instrumentation: a review
  195. The effect of limited exposure to antimycotics on the relative cell-surface hydrophobicity and the adhesion of oral Candida albicans to buccal epithelial cells
  196. Subgingival microbiota of shallow periodontal pockets in individuals after head and neck irradiation
  197. The relationship between the cell length, adhesion to acrylic and relative cell surface hydrophobicity ofCandida parapsilosis
  198. Scanning electron microscopy of microbial colonization of ‘rapid’ and ‘slow’ dental-plaque formers in vivo
  199. A microbiological study of pre- and postoperative apicectomy sites
  200. Southeast Asian Division 11th Annual Scientific Meeting October 4-5, 1996 Jakarta, Indonesia
  201. Miconazole lacquer in the treatment of denture stomatitis: clinical and microbiological findings in Chinese patients
  202. Adenine auxotrophic heterozygosity inCandida krusei
  203. The effect of oral commensal bacteria on candidal adhesion to human buccal epithelial cells in vitro
  204. Predominant cultivable microflora of supragingival dental plaque in Chinese individuals
  205. Ebola virus infection: an overview
  206. The oral prevalence of aerobic and facultatively anaerobic gram-negative rods and yeasts in semi-recluse human vegetarians
  207. Oral Candida albicans biotypes in chinese patients with and without oral candidosis
  208. Screening for hepatitis B before admission to dental school
  209. Biotypes of oral Candida albicans isolates in human immunodeficiency virus-infected patients from diverse geographic locations
  210. Adhesion and colonisation of Candida krusei on host surfaces
  211. The effect of antifungal agents on the in vitro susceptibility of Candida albicans to apo-lactoferrin
  212. The effect of indigenous bacterial populations on buccal epithelial cells on subsequent microbial adhesion in vitro
  213. The oral prevalence of aerobic and facultatively anaerobic gram-negative rods and yeasts in Hong Kong Chinese
  214. Needle-stick injuries and transmission of HIV to HCWs'
  215. The fungicidal effect of human lactoferrin on Candida albicans and Candida krusei
  216. Attitudes to cross-infection measures of UK and Hong Kong patients
  217. HIV: answers to common questions on transmission, disinfection and antisepsis in clinical dentistry
  218. Interactions between denture lining material, protein pellicles and Candida albicans
  219. Revised guidelines for HIV-infected health care workers
  220. Chronic hyperplastic candidosis and secretor status
  221. Oral candidosis in the elderly in long term hospital care
  222. Systemic fluconazole therapy and in vitro adhesion of Candida albicans to human buccal epithelial cells
  223. Suppurative oral candidosis
  224. The surgical mask unmasked: A review
  225. Increasing acceptance of hepatitis B vaccine by dental personnel but reluctance to accept hepatitis B carrier patients
  226. Pagiarism claim
  227. In vitro studies on candida, antimycotics and oral defences
  228. The post-antifungal effect (PAFE) and its impact on the pathogenic attributes of Candida albicans
  229. Epstein-barr virus shedding and cytokine alterations in the oropharynx during HIV-1 infection
  230. Communal interactions of Candida and bacteria in mixed species biofilms
  231. Phylogenetic aspects of oral bacterial microbiome
  232. Molecular microbiology of candida biofilms
  233. The impact of the oral environment on Candida biofilm development
  234. Expression and regulation of human β-defensins in gingival epithelia
  235. Ultrastructural, histochemical and molecular features of the invasive phase of candida species
  236. Molecular and phenotypic characteristics of the genus actinomyces with particular reference to the human oral cavity
  237. Predominant cultivable putative pathogens in Chinese adults with and without periodontal diseases
  238. Randomly Amplified Polymorphic DNA Fingerprinting: The Basics
  239. Genotyping Candida species and molecular analysis of C. albicans gene encoding mevalonate pyrophosphate decarboxylase